Back To Search Instructions
8 protocols meet the specified criteria
Phase: 1
Protocol No.TitleStatus
1100000082Phase I Dose Escalation Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab in Stage IV Non-Squamous Non- Small Cell Lung CancerOpen
1100000353A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma (M12-175) Open
1300000483Chronic Oral Bicarbonate Feasibility StudyOpen
1300000486M13-835: An Extension Study of ABT-199 in Subjects with Advanced Non-Hodgkin's LymphomaOpen
1300000498M13-364: A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-199Open
1300000612A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced or Refractory Solid Tumors or Lymphoma Open
1300000725A Cardiac Safety Study of TH-302 in Patients with Advanced Solid Tumors Open
1300000748A Phase 1b Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Relapsed or Refractory Multiple Myeloma Subjects who are Receiving Bortezomib and Dexamethasone as their Standard Therapy Open